-+ 0.00%
-+ 0.00%
-+ 0.00%

REGENXBIO SHARES DOWN 25% PREMARKET AFTER FDA PLACES CLINICAL HOLD ON CO'S GENE THERAPY FOR HUNTER SYNDROME

Reuters·08/24/2026 11:42:15

Please log in to view news